EUVIMEDEUVIMED entdecken
Crossref

Impact of Substantial Weight Loss on Digoxin Intoxication During Long-term Therapy

Hirokazu Nakayama iD, Tsuyoshi Shiga, Masayo Tanaka

Annals of Pharmacotherapy · 2025

DOI: 10.1177/10600280251369114 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Pharmacotherapy, 2025. Verfasst von Hirokazu Nakayama und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, NTT Medical Center Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Digoxin, Weight Loss. Die Arbeit nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Despite numerous safety studies on digoxin, the association of substantial body weight loss with the development of digoxin intoxication and the transition of risk factors over time in patients on long-term digoxin treatment remain unclear.

Objective

This study aimed to reveal whether the risk factors of digoxin intoxication, including substantial body weight loss, change over the course of treatment.

Methods

A retrospective study was conducted in adult patients newly prescribed digoxin between January 2010 and December 2021. Multiple logistic analysis was performed to identify clinical features associated with digoxin intoxication over time.

Results

A total of 329 patients followed for a median period of 139 (interquartile range, 29-909) days were selected for analysis. Among them, 36 patients (11%) developed digoxin intoxication. Multivariate analysis identified concomitant diuretics (odds ratio, 36.64; 95% confidence interval, 5.77-232.56), comorbid cancer (8.76; 1.95-39.31), estimated glomerular filtration rate (eGFR) reduction ≥ 30% from baseline (9.01; 2.31-35.16), and hemodialysis (47.30; 5.77-387.49) as risk factors associated with digoxin intoxication occurring within 6 months of digoxin treatment; while weight loss >6% during the last 6-12 months (16.07; 2.99-86.48), and eGFR reduction ≥ 30% from baseline (11.55; 2.37-56.35) were risk factors of intoxication occurring after 6 months of treatment. Conclusion and relevance: Concomitant diuretics and comorbid cancer were risk factors of digoxin intoxication during early treatment, whereas substantial body weight loss ≥ 6% became the risk factor after prolonged treatment, and impaired renal function was the risk factor spanning early to prolonged treatment. Thus, transition of risk factors of digoxin intoxication during prolonged course of treatment was observed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DigoxinWeight LossHumansMaleRetrospective StudiesFemaleMiddle AgedAgedRisk FactorsGlomerular Filtration RateDiureticsAdultTime Factors

Stichwörter der Autor:innen

body weight lossdigoxinintoxicationserum digoxin concentration

Substanzen

DigoxinDiuretics

Autor:innen und Institutionen

  • Department of Pharmacy, NTT Medical Center Tokyo, Tokyo, Japan.
  • Department of Clinical Pharmacology and Therapeutics, School of Medicine, The Jikei University, Tokyo, Japan.

ORCID-Profile: Hirokazu Nakayama

Zitieren

APA

Nakayama, H., Shiga, T., & Tanaka, M. (2025). Impact of Substantial Weight Loss on Digoxin Intoxication During Long-term Therapy. Annals of Pharmacotherapy. https://doi.org/10.1177/10600280251369114

Vancouver

Nakayama H, Shiga T, Tanaka M. Impact of Substantial Weight Loss on Digoxin Intoxication During Long-term Therapy. Annals of Pharmacotherapy. 2025. doi:10.1177/10600280251369114

BibTeX
@article{Nakayama2025,
  author = {Nakayama, Hirokazu and Shiga, Tsuyoshi and Tanaka, Masayo},
  title = {Impact of Substantial Weight Loss on Digoxin Intoxication During Long-term Therapy},
  journal = {Annals of Pharmacotherapy},
  year = {2025},
  doi = {10.1177/10600280251369114}
}
Kostenlos starten →